Triple-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Triple-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-12-05FDA Approved: TRODELVY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for TRODELVY (sacituzumab govitecan) filed by Gilead Sciences, resulting in labeling changes for…